INmune Bio Co-Founder and CEO RJ Tesi Presents at Cambridge Healthcare Institute’s 7th Annual Immuno-Oncology Summit

    NEXT STORY
    Generex Biotechnology Welcomes MediSource Partners to the NuGenerex Family of Companies
    PREV STORY
    Progenics Pharmaceuticals Sets Second Quarter 2019 Financial Results and Business Update Call for August 9
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Galena Biopharma Announces Completion of Enrollment in Two NeuVax™ (nelipepimut-S) Clinical Trials in Combination with Trastuzumab

    SAN RAMON, Calif., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...

    author_avatar
    NASDAQ Market News

    SELLAS Life Sciences Completes Second Tranche of $10,700,000 Private Placement

    Proceeds used towards advancement of clinical programs NEW YORK, May 02, 2018 (GLOBE NEWSWIRE) ...

    author_avatar
    NASDAQ Market News

    Aduro Biotech to Present at the Leerink Partners 6th Annual Global Healthcare Conference

    BERKELEY, Calif., Feb. 10, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced ...

    author_avatar
    NASDAQ Market News